Pirnabine
From Wikipedia, the free encyclopedia
 |
|
|---|---|
| Systematic (IUPAC) name | |
| (3,6,6,9-tetramethyl-7,8,9,10-tetrahydrobenzo[c]chromen-1-yl) acetate | |
| Clinical data | |
| Pregnancy cat. | ? |
| Legal status | ? |
| Identifiers | |
| CAS number | 68298-00-0 |
| ATC code | ? |
| PubChem | CID 50137 |
| UNII | S3FHL03F60  |
| Chemical data | |
| Formula | C19H24O3 |
| Mol. mass | 300.391 g/mol |
| SMILES | eMolecules & PubChem |
 (what is this?) (verify) |
Pirnabine (SP-304) is a synthetic cannabinoid receptor ligand, which was developed for the treatment of glaucoma.[1]
